Disruption of cotranscriptional splicing suggests RBM39 is a therapeutic target in acute lymphoblastic leukemia
共转录剪接的破坏提示RBM39是急性淋巴细胞白血病的一个治疗靶点。
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2024024281
Jin, Qi; Harris, Ethan; Myers, Jacquelyn A; Mehmood, Rashid; Cotton, Anitria; Shirnekhi, Hazheen K; Baggett, David W; Wen, Jeremy Qiang; Schild, Andrew B; Bhansali, Rahul S; Klein, Jonathon; Narina, Shilpa; Pieters, Tim; Yoshimi, Akihide; Pruett-Miller, Shondra M; Kriwacki, Richard; Abdel-Wahab, Omar; Malinge, Sebastien; Ntziachristos, Panagiotis; Obeng, Esther A; Crispino, John D
